Wednesday, March 6, 2024

This man left Wall Street to build a stock prediction system

About once a year we come across something that's truly groundbreaking in the world of trading and investing…
�� ‌   ��� ­ �� ‌   ��� ­ �� ‌   ��� ­ �� ‌   ��� ­ �� ‌   ��� ­ �� ‌   ��� ­ �� ‌   ��� ­ �� ‌   ��� ­
  Unsubscribe

Below is a message from one of our sponsors

About once a year we come across something that's truly groundbreaking in the world of trading and investing…

And this time it happens to be a stock prediction system built by a professional trader…
By clicking the link above you agree to periodic updates from The TradingPub and its partners (privacy policy)

According to our research, last year it accurately predicted the rise of all 7 magnificent stocks…

And it did it months before they reached their current highs.

For example, on January 9th, 2023, It flagged NVDA…

12 months later, the stock was trading 257% higher…

It was the same thing with Meta, Microsoft, and the rest of the bunch…

And that's the reason for today's email…

Right now this stock prediction system named “Platform X” just turned bullish for a few NEW stocks for 2024…
By clicking the link above you agree to periodic updates from The TradingPub and its partners (privacy policy)

Obviously, I cannot promise future returns, or against losses.

But it would not be a stretch to see these stocks perform, much like Nvidia, Meta, and Microsoft in 2024…

Now the man, behind Platform X, is no stranger to stock market success…

He's the only trader I know who published 200 winning plays in 2023 with a 70% accuracy rate.

And for the first time ever he's sharing access to his Platform X system.

Not only is he showing folks how to use it, but also sharing his favorite Platform X stocks for free.

To check it out follow this link here and sign up.
By clicking the link above you agree to periodic updates from The TradingPub and its partners (privacy policy)

Enjoy.

The profits and performance shown are not typical. We make no future earnings claims, and you may lose money. These trades expressed are from historical backtested data in order to demonstrate the potential of the system.

 


The above is a paid advertisement. Barchart.com is not affiliated with nor does it endorse any trading system, newsletter or other similar service. Barchart.com does not guarantee or verify any performance claims made by such systems, newsletters or services. Trading involves a significant and substantial risk of loss and may not be suitable for everyone. You should only trade with money you can afford to lose. There is no guarantee that you will profit from your trading activity and it is possible that you may lose all of, or if trading on margin more than, your investment. Some of the results shown may be based on simulated performance.

SIMULATED OR HYPOTHETICAL PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE THE RESULTS SHOWN IN AN ACTUAL PERFORMANCE RECORD, SUCH RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, BECAUSE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MY HAVE UNDER OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED OR HYPOTHETICAL PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

Past performance is not necessarily indicative of future performance. This brief statement cannot disclose all the risks and other significant aspects of trading. You should carefully study trading and consider whether such activity is suitable for you in light of your circumstances and financial resources before you trade.

This message is considered by regulation to be a commercial and advertising message. This is a permission-based message. You are receiving this email either because you opted-in to this subscription or because you have a prior existing relationship with Barchart.com or one of its subsidiaries, and previously provided your email address to us. This email fully complies with all laws and regulations. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking on the unsubscribe or profile link and you will no longer receive this email. We will immediately redress any complaints you may have. If you have any questions, please send an email with your questions to bcmembers@barchart.com.

Barchart.com
222 S. Riverside Plaza, Suite 810 Chicago, IL 60606

Unsubscribe

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...